title: Tsc2 Haploinsufficiency Has Limited Effects on Fetal Brain Cytokine Levels during Gestational Immune Activation.
abstract: Dysregulated TSC/mTOR signaling may play a pathogenetic role in forms of syndromic autism, such as autism associated with tuberous sclerosis, a genetic disorder caused by heterozygous TSC1 or TSC2 mutations. Environmental risk factors, such as gestational viral infections, may, in some cases, also contribute to the pathogenesis of autism and related neuropsychiatric disorders. We have recently found that a heterozygous Tsc2 mutation and the poly I:C model of maternal immune activation (MIA) interactively perturb fetal development and adult social behavior in mice, suggesting that these factors converge on shared pathways. TSC/mTOR signaling plays an important role in the modulation of immune responses, raising the possibility that the damage caused by MIA was greater in Tsc2(+/-) than in wildtype fetuses because of an exacerbated immune response in the mutants. Here, cytokine antibody arrays were employed to measure relative cytokine abundances in the fetal brain and the placenta during MIA. Cytokines were induced by gestational poly I:C but there was no obvious modulatory effect of Tsc2 haploinsufficiency. The data indicate that cytokine exposure during MIA is comparable in Tsc2 haploinsufficient and wildtype control fetuses, suggesting that downstream molecular and cellular processes may account for the interactive effects of Tsc2 haploinsufficiency and MIA.
authors.affiliation: German Center for Neurodegenerative Diseases (DZNE), Ludwig-Erhard-Allee 2, 53175 Bonn, Germany.
authors.forename: Dan
authors.identifier: 0000-0001-7464-1335
authors.initials: D
authors.lastname: Ehninger
references.citation: Nature. 2008 Mar 20;452(7185):323-8
references.pmid: 18272964
references.citation: J Autism Child Schizophr. 1971 Jan-Mar;1(1):33-47
references.pmid: 5172438
references.citation: Mol Psychiatry. 2012 Jan;17(1):62-70
references.pmid: 21079609
references.citation: J Neurosci Res. 2011 Oct;89(10):1575-85
references.pmid: 21732402
references.citation: J Autism Dev Disord. 1998 Dec;28(6):567-71
references.pmid: 9932243
references.citation: J Autism Dev Disord. 1998 Oct;28(5):407-14
references.pmid: 9813776
references.citation: J Pediatr. 1978 Oct;93(4):699-703
references.pmid: 702254
references.citation: J Autism Child Schizophr. 1977 Mar;7(1):69-81
references.pmid: 576606
references.citation: Int J Dev Neurosci. 2005 Apr-May;23(2-3):299-305
references.pmid: 15749254
references.citation: Cell. 2008 Oct 31;135(3):401-6
references.pmid: 18984149
references.citation: J Autism Dev Disord. 1992 Sep;22(3):339-55
references.pmid: 1400103
references.citation: Nature. 2011 Nov 23;480(7375):63-8
references.pmid: 22113615
references.citation: J Neurosci. 2007 Oct 3;27(40):10695-702
references.pmid: 17913903
references.citation: J Med Genet. 2009 Nov;46(11):759-65
references.pmid: 19556253
references.citation: J Neurosci. 2006 May 3;26(18):4752-62
references.pmid: 16672647
references.citation: J Autism Dev Disord. 2004 Oct;34(5):583-6
references.pmid: 15628611
references.citation: Mol Psychiatry. 2000 Nov;5(6):594-603
references.pmid: 11126390
references.citation: Behav Brain Res. 2009 Dec 7;204(2):313-21
references.pmid: 19136031
references.citation: J Autism Dev Disord. 2003 Aug;33(4):455-9
references.pmid: 12959425
references.citation: Nature. 2011 May 25;474(7351):380-4
references.pmid: 21614001
references.citation: Nat Immunol. 2008 Oct;9(10):1157-64
references.pmid: 18758466
references.citation: Ann Neurol. 2005 Jan;57(1):67-81
references.pmid: 15546155
references.citation: Psychopharmacology (Berl). 2003 Sep;169(3-4):308-13
references.pmid: 12748757
references.citation: Trends Mol Med. 2011 Feb;17(2):78-87
references.pmid: 21115397
references.citation: mBio. 2010 Oct 05;1(4):
references.pmid: 20941330
references.citation: Biol Psychiatry. 2010 Aug 15;68(4):368-76
references.pmid: 20674603
references.citation: J Autism Dev Disord. 2003 Aug;33(4):365-82
references.pmid: 12959416
references.citation: Neuron. 2009 Oct 15;64(1):61-78
references.pmid: 19840550
references.citation: Am J Med Genet. 1986 Jan-Feb;23(1-2):359-74
references.pmid: 3953654
references.citation: Dis Model Mech. 2013 Sep;6(5):1185-97
references.pmid: 23744272
references.citation: J Med Genet. 2005 Apr;42(4):318-21
references.pmid: 15805158
references.citation: Neurobiol Dis. 2008 Jun;30(3):303-311
references.pmid: 18378158
references.citation: J Autism Dev Disord. 2010 Dec;40(12):1423-30
references.pmid: 20414802